AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test
Test Name: AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood
Report Delivery: 3 to 4 Weeks
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure.
Test Details
AARS2 gene leukoencephalopathy, progressive, with ovarian failure is a rare genetic disorder characterized by progressive degeneration of the white matter in the brain (leukoencephalopathy) and premature ovarian failure. It is caused by mutations in the AARS2 gene, which provides instructions for making the alanyl-tRNA synthetase 2 enzyme.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be used to identify mutations or variants in the AARS2 gene that may be responsible for the condition.
NGS genetic testing is a powerful tool that allows for the analysis of a large number of genes in a more efficient and cost-effective manner compared to traditional sequencing methods. It can help in diagnosing genetic disorders, providing information about disease prognosis, and guiding treatment decisions.
If a person presents with symptoms suggestive of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be performed to confirm the diagnosis by identifying pathogenic mutations in the AARS2 gene. This information can then be used for genetic counseling, family planning, and potentially guiding treatment options.
Test Name | AARS2 Gene Leukoencephalopathy progressive with ovarian failure Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AARS2 Gene Leukoencephalopathy, progressive, with ovarian failure |
Test Details | AARS2 gene leukoencephalopathy, progressive, with ovarian failure is a rare genetic disorder characterized by progressive degeneration of the white matter in the brain (leukoencephalopathy) and premature ovarian failure. It is caused by mutations in the AARS2 gene, which provides instructions for making the alanyl-tRNA synthetase 2 enzyme. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be used to identify mutations or variants in the AARS2 gene that may be responsible for the condition. NGS genetic testing is a powerful tool that allows for the analysis of a large number of genes in a more efficient and cost-effective manner compared to traditional sequencing methods. It can help in diagnosing genetic disorders, providing information about disease prognosis, and guiding treatment decisions. If a person presents with symptoms suggestive of AARS2 gene leukoencephalopathy, progressive, with ovarian failure, NGS genetic testing can be performed to confirm the diagnosis by identifying pathogenic mutations in the AARS2 gene. This information can then be used for genetic counseling, family planning, and potentially guiding treatment options. |